Outcomes of Adjunctive Therapy with Intravenous Cefoperazone-Sulbactam for Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii

INTRODUCTION: The efficacy of adjunctive therapy with cefoperazone-sulbactam (CEP-SUL) for ventilator-associated pneumonia (VAP) due to carbapenem-resistant A. baumannii (CRAB) is unclear. METHODS: We retrospectively analyzed the therapeutic effect of adding CEP-SUL to standard regimens for VAP due...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Infect Drug Resist
Autores principales: Kanchanasuwan, Siripen, Kositpantawong, Narongdet, Singkhamanan, Kamonnut, Hortiwakul, Thanaporn, Charoenmak, Boonsri, Ozioma F, Nwabor, Doi, Yohei, Chusri, Sarunyou
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018428/
https://ncbi.nlm.nih.gov/pubmed/33824595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S305819
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares